JP2017518370A5 - - Google Patents

Download PDF

Info

Publication number
JP2017518370A5
JP2017518370A5 JP2017515014A JP2017515014A JP2017518370A5 JP 2017518370 A5 JP2017518370 A5 JP 2017518370A5 JP 2017515014 A JP2017515014 A JP 2017515014A JP 2017515014 A JP2017515014 A JP 2017515014A JP 2017518370 A5 JP2017518370 A5 JP 2017518370A5
Authority
JP
Japan
Prior art keywords
seq
pharmaceutical composition
composition according
eczema
filaggrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017515014A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017518370A (ja
JP6810028B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/032972 external-priority patent/WO2015184134A1/en
Publication of JP2017518370A publication Critical patent/JP2017518370A/ja
Publication of JP2017518370A5 publication Critical patent/JP2017518370A5/ja
Application granted granted Critical
Publication of JP6810028B2 publication Critical patent/JP6810028B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017515014A 2014-05-30 2015-05-28 組換え片利共生皮膚微生物による皮膚疾患の治療処置 Active JP6810028B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462005652P 2014-05-30 2014-05-30
US201462005558P 2014-05-30 2014-05-30
US62/005,652 2014-05-30
US62/005,558 2014-05-30
PCT/US2015/032972 WO2015184134A1 (en) 2014-05-30 2015-05-28 Therapeutic tratment of skin disease with recombinant commensal skin microorganisms

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020205127A Division JP2021038271A (ja) 2014-05-30 2020-12-10 組換え片利共生皮膚微生物による皮膚疾患の治療処置

Publications (3)

Publication Number Publication Date
JP2017518370A JP2017518370A (ja) 2017-07-06
JP2017518370A5 true JP2017518370A5 (https=) 2018-07-12
JP6810028B2 JP6810028B2 (ja) 2021-01-06

Family

ID=54699800

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017515014A Active JP6810028B2 (ja) 2014-05-30 2015-05-28 組換え片利共生皮膚微生物による皮膚疾患の治療処置
JP2020205127A Pending JP2021038271A (ja) 2014-05-30 2020-12-10 組換え片利共生皮膚微生物による皮膚疾患の治療処置

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020205127A Pending JP2021038271A (ja) 2014-05-30 2020-12-10 組換え片利共生皮膚微生物による皮膚疾患の治療処置

Country Status (6)

Country Link
US (3) US10702558B2 (https=)
EP (2) EP4144756A1 (https=)
JP (2) JP6810028B2 (https=)
ES (1) ES2929579T3 (https=)
MA (1) MA40057A (https=)
WO (1) WO2015184134A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10702558B2 (en) 2014-05-30 2020-07-07 Azitra Inc Therapeutic treatment of skin disease with recombinant commensal skin microorganisms
EP3448398A4 (en) 2016-04-21 2019-12-18 Naked Biome, Inc. COMPOSITIONS AND METHODS FOR TREATING SKIN DISEASES
WO2018232300A1 (en) * 2017-06-16 2018-12-20 Azitra Inc Compositions and methods for treatment of netherton syndrome with lekti expressing recombinant microbes
JP7373176B2 (ja) * 2017-08-31 2023-11-02 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 皮膚の酵素活性を制御する分子的細菌療法
WO2019050898A1 (en) * 2017-09-05 2019-03-14 Azitra Inc METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY SKIN DISEASE
JP7460531B2 (ja) 2017-12-05 2024-04-02 バイオピーエルエックス，インコーポレイティド 微生物感染を防ぐための方法および組成物
JP7121969B2 (ja) * 2018-02-23 2022-08-19 株式会社北里コーポレーション 培養液保護用液状物
WO2019195714A1 (en) 2018-04-05 2019-10-10 Azitra Inc Methods and compositions for treating skin disease with recombinant microorganisms
AU2019203692B2 (en) * 2018-08-30 2024-12-12 Kenvue Brands Llc Topical composition containing glycerin and yeast extract
US20210395775A1 (en) * 2018-09-26 2021-12-23 Krystal Biotech, Inc. Compositions and methods for the treatment of skin diseases
WO2020076770A1 (en) * 2018-10-08 2020-04-16 Yale University Selective binding and aggregation of human keratin in the skin barrier using human filaggrin subdomains sd67 and sd150
EP3880241A4 (en) * 2018-11-16 2022-08-17 Azitra, Inc. AUXOTROPHIC STRAINS OF STAPHYLOCOCCUS BACTERIA
CZ308231B6 (cs) * 2019-02-11 2020-03-11 BiomCare s.r.o. Kombinované několikastupňové mikrobiální přípravky a způsob jejich aplikace
CA3136115A1 (en) * 2019-04-05 2020-10-08 Azitra Inc Methods and compositions for treating atopic dermatitis with recombinant microorganisms
WO2020257519A1 (en) * 2019-06-19 2020-12-24 Chan Zuckerberg Biohub, Inc. Bacteria-engineered to elicit antigen-specific t-cells
JP2023512215A (ja) * 2020-01-29 2023-03-24 ザ ジャクソン ラボラトリー 細菌混和物
WO2022087065A1 (en) * 2020-10-21 2022-04-28 The Jackson Laboratory Antimicrobial biosensors
CA3204113A1 (en) * 2021-01-05 2022-07-14 Charlotte VEDEL Strains, compositions and methods of use
CA3228922A1 (en) * 2021-10-11 2023-04-20 Ajinomoto Co., Inc. Bacterium modified to express heterologous tat protein

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0637384B2 (ja) * 1985-09-21 1994-05-18 株式会社資生堂 皮膚化粧料
US4659774A (en) 1985-11-01 1987-04-21 American Hoechst Corporation Support for solid-phase oligonucleotide synthesis
DE4221268C2 (de) 1992-06-26 1997-06-12 Lancaster Group Ag Verwendung eines Dermatikums zur Unterstützung des Sauerstofftransportes in der Haut
DE4221255C2 (de) 1992-06-26 1994-09-15 Lancaster Group Ag Phospholipide enthaltendes Kosmetikum
DK2480669T3 (en) * 2009-09-25 2018-02-12 Curna Inc TREATMENT OF FILAGGRIN- (FLG) RELATED DISEASES BY MODULATING FLG EXPRESSION AND ACTIVITY
AU2010321784B2 (en) 2009-11-23 2014-04-24 Research Development Foundation Recombinant filaggrin polypeptides for cell importation
US20130078275A1 (en) * 2010-05-25 2013-03-28 The Board Of Trustees Of The University Of Illinois Novel systems, vectors, and methods for delivery of biomolecules to eukaryotic cells
US9234204B2 (en) 2012-08-07 2016-01-12 TopGeniX, Inc. Topical composition comprising transformed bacteria expressing a compound of interest
KR101491240B1 (ko) 2013-03-15 2015-02-11 현대자동차주식회사 인비저블 슬라이딩 도어 링크 구조
US10702558B2 (en) 2014-05-30 2020-07-07 Azitra Inc Therapeutic treatment of skin disease with recombinant commensal skin microorganisms

Similar Documents

Publication Publication Date Title
JP2017518370A5 (https=)
JP2024009974A5 (https=)
CN108697743B (zh) 用于治疗由痤疮丙酸杆菌引起的感染尤其是痤疮的乳酸菌的组合物
JP2022501330A5 (https=)
EP3849573B1 (en) Bacteriotherapy against proprionibacterium acnes for the treatment of acne
JP2016540825A5 (https=)
CA3132858A1 (en) Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes
ES2682670T3 (es) Lisinas de bacteriófagos de Streptococcus para la detección y tratamiento de bacterias gram positivas
WO2019045248A3 (ko) 주름 개선 활성을 나타내는 펩타이드 및 이의 용도
WO2018013583A3 (en) Medicinal vaginal lactobacillus cocktail
JPWO2019156137A5 (https=)
WO2011013979A3 (ko) 봉독을 유효성분으로 하는 여드름 예방 및 치료용 조성물
JP2017532343A5 (https=)
MX2019003821A (es) Composiciones de aminoacidos y usos de las mismas.
JP2014518849A5 (https=)
NZ627372A (en) Clostridium histolyticum enzymes and methods for the use thereof
JP2019500056A5 (https=)
JP2016521746A5 (https=)
JP2013136622A5 (https=)
RU2018124487A (ru) Лечение внутрипеченочного холестаза и родственных заболеваний печени
JP2014505062A5 (https=)
JP2020524689A5 (https=)
NZ711281A (en) Short bio-active peptides for promoting wound healing
JP2017511133A5 (https=)
PH12013501861A1 (en) Composition for topical use based on ozonized oil